Premium
P3‐295: Reduction of serum cholinesterase by cholinesterase inhibitor (donepezil, galantamine, or rivastigmine)
Author(s) -
Hayashi Kouji,
Hamano Tadanori,
Ishida Aiko,
Fujita Youshi,
Hama Yuka,
Yamamura Osamu,
Nakamoto Yasunari
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.1668
Subject(s) - galantamine , rivastigmine , donepezil , cholinesterase , butyrylcholinesterase , acetylcholinesterase , pharmacology , medicine , adverse effect , dementia , chemistry , aché , disease , biochemistry , enzyme